A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet

Inclusion Criteria: * Healthy subject, aged 19- 50 years Exclusion Criteria: * History of clinically significant and active disease * History of gastrointestinal disease * History of clinically significant hypersensitivity to study drug, any other drug * Laboratory test serum AST or ALT \> 1.25 times of upper normal range serum total bilirubin \> 1.5 times of upper normal range eGFR \< 60 ml/min/1.73m² serological test(HBsAg, HCV Ab, HIV Ag/Ab, Syphilis reagin) positive * Hypotension or hypertension * Pregnant or nursing women * Participation in any other study within 90 days